Ascendis Pharma
ASND
#1641
Rank
โ‚น1.127 T
Marketcap
โ‚น18,456
Share price
-1.51%
Change (1 day)
65.02%
Change (1 year)

Revenue for Ascendis Pharma (ASND)

Revenue in 2025 (TTM): โ‚น63.10 Billion

According to Ascendis Pharma 's latest financial reports the company's current revenue (TTM ) is โ‚น65.32 Billion. In 2024 the company made a revenue of โ‚น33.24 Billion an increase over the revenue in the year 2023 that were of โ‚น24.24 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Ascendis Pharma from 2014 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น63.10 B89.81%
2024 โ‚น33.24 B37.09%
2023 โ‚น24.24 B447.4%
2022 โ‚น4.42 B567.18%
2021 โ‚น0.66 B14.09%
2020 โ‚น0.58 B-45.52%
2019 โ‚น1.06 B26.17%
2018 โ‚น0.84 B657.64%
2017 โ‚น0.11 B-67.76%
2016 โ‚น0.34 B-41.56%
2015 โ‚น0.59 B-49.14%
2014 โ‚น1.16 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Advaxis
ADXS
โ‚น10.24 M-99.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Affimed
AFMD
โ‚น86.4 M-99.87%๐Ÿ‡ฉ๐Ÿ‡ช Germany
Akebia Therapeutics
AKBA
โ‚น20.21 B-69.05%๐Ÿ‡บ๐Ÿ‡ธ USA